NCT00000660View on ClinicalTrials.gov

Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

Not specified

Study Completion Date

July 31, 1992

Conditions
Sarcoma, KaposiHIV Infections
Interventions
DRUG

Etoposide

Trial Locations (6)

10016

Bellevue Hosp / New York Univ Med Ctr, New York

10021

Mem Sloan - Kettering Cancer Ctr, New York

10025

Saint Luke's - Roosevelt Hosp Ctr, New York

14642

Univ of Rochester Medical Center, Rochester

29169

Julio Arroyo, West Columbia

941102859

San Francisco Gen Hosp, San Francisco

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000660 - Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma | Biotech Hunter | Biotech Hunter